KR900014387A - 디아제핀 항알레르기제 - Google Patents
디아제핀 항알레르기제 Download PDFInfo
- Publication number
- KR900014387A KR900014387A KR1019900003870A KR900003870A KR900014387A KR 900014387 A KR900014387 A KR 900014387A KR 1019900003870 A KR1019900003870 A KR 1019900003870A KR 900003870 A KR900003870 A KR 900003870A KR 900014387 A KR900014387 A KR 900014387A
- Authority
- KR
- South Korea
- Prior art keywords
- methyl
- alkyl
- pyrid
- ring
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (11)
- 일반식(Ⅰ),(Ⅱ) 또는 (Ⅲ)의 화합물 및 약제학적으로 허용되는 이의 염.상기식에서, A는 융합된 벤젠, 피리딘, 나프탈렌, 퀴놀린, 티오펜, 벤조티오펜, 피라졸 또는 이소티아졸 환으로서, 환(들)은 C1-C4알킬, C4-C7사이클로알킬, 할로, 퍼플루오로-(C1-C4알킬), 시아노 (C1-C4알콕시)-카보닐, 니트로, 아미노 (C1-C4알킬)설포닐에 의해 치환된 아미노, (C1-C4알킬) 옥살릴에 의해 치환된 아미노, C1-C4알콕시-(C1-C4알킬)아미노, 하이드록시(C1-C4알킬), (C1-C4알콕시)-C1-C4알킬, (C1-C4알콕시)-(C2-C4알콕시)-C1-C4알킬, -CONR5R6(여기서, R5및 R6는 각각 독립적으로 H 또는 C1-C6알킬이거나, R5는 H 또는 C1-C4알킬이고 R6는 C3-C7사이클로알킬 또는 2-피리딜이거나, R5및 R6는 이들이 결합된 질소원자와 함께 모르폴리노, 피롤리디노 또는 피페리디노그룹을 형성한다), 및 할로겐, 시아노, 트리플루오로 메틸, (C1-C4알콕시)카보닐 또는 카바모일에 의해 임의 치환된 페닐, 티에닐 또는 피리딜중에서 독립적으로 선택된 1 또는 2개의 치환체에 의해 임의 치환되며, X는 O,S 또는 NH이고, Y는 1,4-페닐렌 또는 구조식의 그룹이며, R1은 H또는 페닐, 할로페닐, 피리딜, (C1-C4알콕시) 카보닐 및 디-(C1-C4알킬)아미노 중에서 선택된 치환체에 의해 임의 치환된 C1-C4알킬이거나, 하이드록실 또는 1 또는 2개의 C1-C4알콕시 그룹에 의해 치환된 C2-C4알킬이거나, (CH2)nCONR7R8(여기서 n은 1내지4이고, R7및 R8은 각각 독립적으로 H 또는 C1-C4알킬이다)이고, R2는 H 또는 C1-C4알킬이며, R3는 H 또는 C1-C4알킬이고, B는 1 내지 4개의 질소원자를 함유하는 융합된 5-원헤테로사이클릭 환 또는 2개의 질소원자를 함유하는 융합된 6-원 헤테로사이클릭 환으로서, 상기 5-또는 6-원 환은 C1-C4알킬, C1-C4할로알킬, 할로 및 옥소중에서 독립적으로 선택된 1 또는 2개의 치환체에 의해 임의 치환되며, “Het”는 2 또는 3개의 질소원자를 함유하는 5-원 방향족 헤테로사이클릭 환이거나 피리딘 환으로서, 상기 환은 벤젠 또는 피리딘 환에 또는 추가의 5-원 방향족 헤테로사이클릭 환에 임의로 융합될 수 있고, 하나 이상의 상기 헤테로사이클릭 환은 임의로 황 또는 산소원자를 함유하며, 하나 이상의 상기 환은 C1-C4알킬, C1-C4알콕시, 할로, CF3, CN 및 포르밀 중에서 독립적으로 선택된 1내지 3개의 치환체로 임의치환되고, 점선은 임의의 결합을 나타낸다.
- 제 1항에 있어서, A가 융합된 벤젠, 디메틸 벤젠, 디클로로벤젠, 니트로벤젠, 아닐린, 플루오로벤젠, 클로로-벤젠, 피리딘, 퀴놀린, 메틸피리딘, 디메틸피리딘, 에톡시카보닐피리딘, 피리드-2-일 카바모일피리딘, 모르폴리노카보닐피리딘, 디에틸카바모일피리딘, 3급-부틸 카바모일피리딘, 티오펜, 2-메톡시카보닐-5-메틸-티오펜, 1-메틸-3-페닐-피라졸, 1-페닐-3-메틸피라졸, 1,2-디메틸 피라졸, 1,3-디메틸피라졸, 1-피리드-2-일-3-메틸-피라졸, 1-3급-부틸-3-메틸피라졸, 1-(2-하이드록시에틸)-3-메틸피라졸, 1-메틸-3-피리드-3-일피라졸, 1-메틸-3-피리드-4-일피라졸, 1-메틸-3-피리드-2-일피라졸, 1-(2-하이드록시 에틸)-3-페닐-피라졸, 3-(2-메톡시에톡시)메틸-1-메틸피라졸, 1-메틸-3-사이클로헥실-피라졸, 1-메틸-3-하이드록시-메틸피라졸, 3-사이클로헥실피라졸, 1-메틸-3-(3-이소부톡시메틸)피라졸, 1-메틸-3-(4-클로로페닐)피라졸, 1-메틸-3-이소프로필피라졸, 1-피리드-2-일-3-페닐피라졸, 1-메틸-3-(2-클로로페닐)피라졸, 1-메틸-3-(3-트리플루오로메틸)페닐피라졸, 1-메틸-3-티에닐피라졸, 브로모피리딘, 1-에톡시-에틸이미노벤젠, N-에틸설폭시아닐린, 3-메틸이소티아졸 또는 에톡시카보닐카브아미도 벤젠환인 화합물.
- 제 1항 또는 2항에 있어서, R1이 H, 메틸, 에틸, 벤질, 4-클로로벤질, -CH2CO2Et, -CH2CH2N(CH3)2, -CH2CON(CH3)2, -CH2CH2CH(OCH3)2또는 4-하이드록시부틸인 화합물.
- 제 1항 또는 2항에 있어서, 융합된 환B가 이미다졸, 메틸이미다졸, 트리아졸, 메틸트리아졸, 트리플루오로메틸트리아졸, 트리아졸론, 테트라졸, 피리미돈, 이미다졸린 또는 테트라하이드로 피리미딘 환인 합성물.
- 제 1항 내지 4항중 어느 한 항에 있어서, R2및 R3가 독립적으로 수소 또는 메틸인 화합물.
- 제 1항 내지 5항중 어느 한 항에 있어서, “Het”가 디메틸피리딜 1또는 2개의 C1-C4알킬 그룹에 의해 임의로 치환된 1,2,4-트리아졸릴, 또는 C1-C4알킬, 할로 및 프로밀 중에서 선택된 3개 이하의 그룹으로 임의 치환되거나 C1-C4알킬 또는 CF3그룹으로 임의 치환되고 벤젠, 티아졸 또는 피리딘 환에 융합된 이미다졸릴인 화합물.
- 제 6항에 있어서, Het가 2-메틸-이미다조[4,5-c]피리드-1-일, 2,4,6-트리메틸이미다조[4,5-c]피리드-1-일, 3,5-디메틸-1,2,4-트리아졸-4-일, 1,6-디메틸피리드-3-일, 5-클로로-2-메틸-이미다졸-1-일, 5-클로로-4-포르밀-2-메틸이미다조-1-일 또는 4-메틸이미다조[2,1-b]티아졸-5-일인 화합물.
- 8,9-디클로로-5-[4-(2-메틸-1H-이미다조[4,5-c]피리드-1-일)페닐]-4H-이미다조[1,2-a][1,5]벤조디아제핀, 8,9-디클로로-1-메틸-5-[4-(2-메틸-이미다조[4,5-c]피리드-1-일)페닐]-4H-이미다조[1,2-a][1,5]벤조디아제핀, 3,5-디하이드로-2-[4-(2-메틸이미다조[4,5-c]피리드-1-일)페닐]-5,7,9-트리메틸-1H-피리도[2,3-b][1,4]디아제핀-4-온, 8-브로모-3,5-디하이드로-1-메틸-2-[4-(2-메틸이미다조[4,5-c]피리드-1-일)페닐]-4H-피리도[2,3-b][1,4]디아제핀-4-온, 1,3-디하이드로-1,8-디메틸-6-메톡시카보닐-4-[4-(2-메틸이미다조[4,5-c]피리드-1-일)페닐]-2H-티에노[3,4-b]디아제핀-2-온,5-[4-(2-메틸이미다조[4,5-c]피리드-1-일)페닐]-1,6,7,8-테트라하이드로-1,3,8-트리메틸-피라졸로[3,4-b][1,4]디아제핀-7-온, 3-사이클로헥실-1,8-디메틸-5-[4-(2-메틸이미다조[4,5-c]피리드-1-일)페닐]-1,6,7,8-테트라하이드로피라졸로[3,4-b][1,4]디아제핀-7-온, 8-브로모-S-[4-(2-메틸이미다조[4,5-c]피리드-1-일)페닐]-4H-이미다조-[1,2-a]피리도[2,3-b][1,4]디아제핀, 또는 1,6,7,8-테트라하이드로-1,8-디메틸-5-[4-(2-메틸-1H-이미다조[4,5-c]피리드-1-일)페닐]-7-옥소-3-(3-피리딜)피라졸로[3,4-b][1,4]-디아제핀 및 약제학적으로 허용되는 이들의 염.
- 제 1항 내지 8항에 있어서, 약제에 사용하기 위한 화합물.
- 혈소판 활성화 인자 길항용 약제 제조를 위한 제 1항 내지 8항중 어느 한 항에 따르는 화합물의 용도.
- 제 1항 내지 8항중 어느 한 항에 따르는 화합물 및 약제학적으로 허용되는 희석제 또는 담체를 함유함을 특징으로 하는 약제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8906813.4 | 1989-03-23 | ||
GB89068134 | 1989-03-23 | ||
GB898906813A GB8906813D0 (en) | 1989-03-23 | 1989-03-23 | Therapeutic agents |
GB898926246A GB8926246D0 (en) | 1989-11-21 | 1989-11-21 | Therapeutic agents |
GB8926246.3 | 1989-11-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR900014387A true KR900014387A (ko) | 1990-10-23 |
KR920003981B1 KR920003981B1 (ko) | 1992-05-21 |
Family
ID=26295132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900003870A KR920003981B1 (ko) | 1989-03-23 | 1990-03-22 | 디아제핀 항알레르기 화합물 |
Country Status (21)
Country | Link |
---|---|
US (1) | US5008263A (ko) |
EP (1) | EP0389189B1 (ko) |
JP (1) | JPH0684371B2 (ko) |
KR (1) | KR920003981B1 (ko) |
CN (1) | CN1045783A (ko) |
AT (1) | ATE105839T1 (ko) |
AU (1) | AU627286B2 (ko) |
CA (1) | CA2012666C (ko) |
DE (1) | DE69008906T2 (ko) |
DK (1) | DK0389189T3 (ko) |
ES (1) | ES2052172T3 (ko) |
FI (1) | FI98463C (ko) |
HU (1) | HUT61006A (ko) |
IE (1) | IE62857B1 (ko) |
IL (1) | IL93776A (ko) |
MY (1) | MY106322A (ko) |
NO (1) | NO175151C (ko) |
NZ (1) | NZ233047A (ko) |
PH (1) | PH27513A (ko) |
PT (1) | PT93526B (ko) |
YU (1) | YU47344B (ko) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9010404D0 (en) * | 1990-05-09 | 1990-06-27 | Pfizer Ltd | Therapeutic agents |
GB9015524D0 (en) * | 1990-07-13 | 1990-08-29 | Pfizer Ltd | Therapeutic agents |
GB9019409D0 (en) * | 1990-09-05 | 1990-10-17 | Pfizer Ltd | Therapeutic agents |
GB9019833D0 (en) * | 1990-09-11 | 1990-10-24 | Pfizer Ltd | Therapeutic agents |
US5939412A (en) * | 1992-06-26 | 1999-08-17 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
WO1993000095A2 (en) * | 1991-06-28 | 1993-01-07 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
IL108524A0 (en) * | 1993-02-03 | 1994-05-30 | Gensia Inc | Imidazodiazepine analogs |
US5500439A (en) * | 1993-12-09 | 1996-03-19 | Alteon Inc. | Aminopyrazoles |
MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
JPH10500402A (ja) * | 1994-04-29 | 1998-01-13 | 武田薬品工業株式会社 | 縮合複素環化合物またはその塩、その製造法および用途 |
US6458784B1 (en) | 1994-06-29 | 2002-10-01 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
FR2733749B1 (fr) * | 1995-05-05 | 1997-06-13 | Oreal | Compositions pour la teinture des fibres keratiniques contenant des diamino pyrazoles, procede de teinture, nouveaux diamino pyrazoles et leur procede de preparation |
US5726171A (en) * | 1995-06-07 | 1998-03-10 | Merck & Co Inc | N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides |
US5977101A (en) * | 1995-06-29 | 1999-11-02 | Smithkline Beecham Corporation | Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity |
ES2294789T3 (es) * | 1995-08-15 | 2008-04-01 | Bayer Cropscience Ag | Derivados de indazol pesticidas. |
US6458823B1 (en) | 1998-06-08 | 2002-10-01 | Wyeth | Diaminopyrazoles |
US6172222B1 (en) * | 1998-06-08 | 2001-01-09 | American Home Products Corporation | Diaminopyrazoles |
US6949542B2 (en) * | 2002-02-06 | 2005-09-27 | Hoffman-La Roche Inc. | Dihydro-benzo[b][1,4]diazepin-2-one derivatives |
US8546377B2 (en) | 2009-04-23 | 2013-10-01 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
US8518933B2 (en) | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
TW201307347A (zh) | 2010-11-01 | 2013-02-16 | Arqule Inc | 經取代苯並-咪唑並-吡啶並-二氮呯化合物 |
KR101675984B1 (ko) * | 2015-02-23 | 2016-11-14 | 한양대학교 에리카산학협력단 | 티에노디아제핀 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 약학적 조성물 |
CN105153195B (zh) * | 2015-09-01 | 2017-09-26 | 汤文建 | 一种三环吡唑[1,5‑d][1,4]苯并氧氮杂卓酮衍生物及其制备方法与用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU527689B2 (en) * | 1974-09-11 | 1983-03-17 | F. Hoffmann-La Roche & Co. | Imidazodiazepine derivatives |
DK476885D0 (da) * | 1985-10-17 | 1985-10-17 | Ferrosan As | Heterocycliske forbindelser og fremgangsmaader til fremstilling heraf |
ES2037013T3 (es) * | 1986-01-21 | 1993-06-16 | Boehringer Ingelheim Kg | Procedimiento para preparar tieno-1,4-diazepinas. |
-
1990
- 1990-03-15 ES ES90302826T patent/ES2052172T3/es not_active Expired - Lifetime
- 1990-03-15 DK DK90302826.4T patent/DK0389189T3/da active
- 1990-03-15 DE DE69008906T patent/DE69008906T2/de not_active Expired - Fee Related
- 1990-03-15 EP EP90302826A patent/EP0389189B1/en not_active Expired - Lifetime
- 1990-03-15 AT AT90302826T patent/ATE105839T1/de not_active IP Right Cessation
- 1990-03-16 IL IL9377690A patent/IL93776A/en not_active IP Right Cessation
- 1990-03-20 US US07/496,393 patent/US5008263A/en not_active Expired - Fee Related
- 1990-03-21 CA CA002012666A patent/CA2012666C/en not_active Expired - Fee Related
- 1990-03-21 PT PT93526A patent/PT93526B/pt not_active IP Right Cessation
- 1990-03-21 MY MYPI90000443A patent/MY106322A/en unknown
- 1990-03-22 IE IE105590A patent/IE62857B1/en not_active IP Right Cessation
- 1990-03-22 NO NO901329A patent/NO175151C/no unknown
- 1990-03-22 NZ NZ233047A patent/NZ233047A/en unknown
- 1990-03-22 PH PH40251A patent/PH27513A/en unknown
- 1990-03-22 AU AU52148/90A patent/AU627286B2/en not_active Ceased
- 1990-03-22 FI FI901441A patent/FI98463C/fi not_active IP Right Cessation
- 1990-03-22 YU YU56390A patent/YU47344B/sh unknown
- 1990-03-22 HU HU901794A patent/HUT61006A/hu unknown
- 1990-03-22 KR KR1019900003870A patent/KR920003981B1/ko not_active IP Right Cessation
- 1990-03-23 JP JP2075339A patent/JPH0684371B2/ja not_active Expired - Lifetime
- 1990-03-23 CN CN90101559A patent/CN1045783A/zh not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900014387A (ko) | 디아제핀 항알레르기제 | |
ES2373672T3 (es) | Derivados de pirrolo[2,3-c]piridina y procesos para su preparación. | |
Shawali | Synthesis and tautomerism of aryl-and hetaryl-azo derivatives of bi-and tri-heterocycles | |
CA2521929A1 (en) | Condensed n-heterocyclic compounds and their use as crf receptor antagonists | |
PL101248B1 (pl) | Sposob wytwarzania nowych pochodnych piroliny | |
CS249146B2 (en) | Method of new imidazodiazepine's derivatives production | |
KR920014804A (ko) | 아릴 (또는 헤테로아릴) 피페라지닐알킬아졸 유도체 및 그의 제조방법 및 그의 의약품으로의 이용 | |
Elwahy et al. | Synthesis of trifluoromethyl-substituted fused bicyclic heterocycles and their corresponding benzo-fused analogues | |
KR890002115A (ko) | 위산 분비 억제 작용을 갖는 티오메틸 및 술피닐메틸 유도체, 그의 제조 방법 및 이를 함유하는 제약 조성물 | |
KR970005844B1 (ko) | 새로운 세파로스포린 화합물 및 항균제 | |
Abdelhamid et al. | Pyrazole-carboxaldehydes as versatile precursors for different pyrazole-substituted heterocyclic systems | |
MX2022015311A (es) | N-(fenilaminocarbonil) tetrahidro-isoquinolinas y compuestos relacionados como moduladores de gpr65. | |
DK156477C (da) | Analogifremgangsmaade til fremstilling af heterocyclisk substituerede tetrahydro-thiopyran- eller -thiophen-carbothio-amid-derivater | |
El-Sayed et al. | Synthesis and Reactions of Five-Membered Heterocycles Using Phase Transfer Catalyst (PTC) Techniques | |
DE68922287T2 (de) | Imidazol und Pyridyl-Derivate von Phenyl substituierten 1,4-Dihydropyridinen und Verfahren zu ihrer Herstellung. | |
YU48849B (sh) | Benzimidazoli, njihove 1-,3-izomerne smeše i njihove soli kao i postupak za njihovo dobijanje | |
Brzozowski et al. | JOURNAL OF HETREROCYCLIC CHEMISTRY Vol. 51-2014 | |
Lang Jr et al. | Five-membered ring systems: With more than one N atom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19950417 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |